CN Bio raised $21 million in a first close of its Series B fundraising round with Bayland Capital and founding shareholder, CN Innovations Holdings.

AI (big data) Biotech Software Services

Investments

14 April 2024

CN Bio (company)

AI (big data) Biotech Software Services

Total investments received (USD): 33m

Round value (USD): 21m

Round investors: Bayland Capital

Company: CN Bio

Industry: AI (big data) Biotech Software Services

AI (big data) Software Services

Investments 12 October 2024

AI (big data) Competitive Intelligence Software Services

Investments 09 September 2024

AI (big data) Software Services

Investments 21 August 2024

AI (big data) Software Services

Investments 20 August 2024

AI (big data) Competitive Intelligence Software Services

Investments 18 August 2024